Primary care pharmacists’ knowledge and perception of Inflammatory Bowel Disease: a cross-sectional study in Australia.


  • Sharmila S Prasad The University of Newcastle
  • Simon Keely The University of Newcastle
  • Nicholas J Talley The University of Newcastle
  • Kerith Duncanson The University of Newcastle
  • Therése Kairuz The University of Newcastle
  • Michael P Jones Macquarie University
  • Marjorie M Walker The University of Newcastle



Purpose: Inflammatory bowel disease (IBD) management is complex and challenging, and therefore, requires a multidisciplinary approach. Whilst pharmacists may play a key role as the first point of contact for patients with initial symptoms or disease relapse, there is scant literature on pharmacists’ knowledge in IBD management. We conducted a survey to explore pharmacists’ knowledge and their perception of pharmacists and other healthcare professionals’ roles in managing patients with IBD.

Design and Methodology: An online survey was distributed to pharmacists through professional organisations. The survey included questions about demographic information, concepts related to IBD management and the roles of pharmacists and healthcare professionals in managing patients with IBD.

Findings: Fifty two respondents completed the survey. The overall knowledge score for the majority of respondents was categorised as ‘low’ (25-50%) to ‘average’ (51-75%). IBD concept that demonstrated the highest level of accuracy in knowledge scores among pharmacists was the importance of vaccination in IBD (94.2%). Pharmacists who had exposure to patients with IBD  demonstrated better knowledge scores compared to those who did not have any exposure to IBD patients in their practice (p = 0.005). Furthermore, General Practitioners (GPs) were perceived as the key care providers to IBD patients, whilst pharmacists considered themselves as important in providing medication related information to patients. 

Conclusion: This study indicated that pharmacists’ knowledge of IBD and its’ management was suboptimal, but with education and training there are opportunities for pharmacists to play a more active role in managing patients with IBD.


ANDREWS, J. M., MOUNTIFIELD, R. E., VAN LANGENBERG, D. R., BAMPTON, P. A. & HOLTMANN, G. J. 2010. Un-promoted issues in inflammatory bowel disease: opportunities to optimize care. Intern Med J, 40, 173-82.

AUSTRALIAN BUREAU OF STATISTICS. 2018. Asthma - National Health Survey: First Results, 2017-18 [Online]. Available: [Accessed 9 November 2020].

AUSTRALIAN INSTITUTE OF HEALTH AND WELFARE (AIHW). 2018. Australia's health 2018 [Online]. Available: [Accessed 9 November 2020].

BENNETT, A. L., MUNKHOLM, P. & ANDREWS, J. M. 2015. Tools for primary care management of inflammatory bowel disease: do they exist? World J Gastroenterol, 21, 4457-65.

BLACKBURN, D. F., FOWLER, S., CRAWLEY, A., GERWING, S., ALCORN, J., MANSELL, H., EVANS, C., MANSELL, K., TAYLOR, J., JORGENSON, D., LAROCQUE, D., ROTTER, T. & SHEVCHUK, Y. 2019. An Advanced Pharmacy Practice Experience for Community Pharmacies Based on a Clinical Intervention Targeting Patients With Inflammatory Bowel Disease. J Pharm Pract, 897190019857410.

CHARAN, J. & BISWAS, T. 2013. How to calculate sample size for different study designs in medical research? Indian J Psychol Med, 35, 121-6.

COLOMBEL, J. F., D'HAENS, G., LEE, W. J., PETERSSON, J. & PANACCIONE, R. 2020. Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review. J Crohns Colitis, 14, 254-266.

CROHN'S & COLITIS AUSTRALIA. 2017. Inflammtory Bowel Disease Audit - final report of the first audit of the organisation and provision of IBD services in Australia 2016 [Online]. Crohn's Colitis Australia (CCA). Available:

[Accessed 9 November 2020].

CROHN'S & COLITIS AUSTRALIA (CCA). 2016. Australian IBD Standards: Standards of healthcare for people with inflammatory bowel disease in Australia [Online]. Available: [Accessed 9 November 2020].

DELOITTE ACCESS ECONOMICS PTY LIMITED. 2007. The Economic Costs of Crohn's Disease and Ulcerative Colitis [Online]. Available:

[Accessed 9 November 2020].

GASTROENTEROLOGICAL SOCIETY OF AUSTRALIA. 2018. Inflammatory Bowel Disease Clinical Update Fourth Edition Updated 2018 [Online]. Available:

[Accessed 8 November 2020].

GEORGE, P. P., MOLINA, J. A., CHEAH, J., CHAN, S. C. & LIM, B. P. 2010. The evolving role of the community pharmacist in chronic disease management - a literature review. Ann Acad Med Singapore, 39, 861-7.

GEORGY, M., NEGM, Y. & EL-MATARY, W. 2019. Quality improvement in healthcare for patients with inflammatory bowel disease. Transl Pediatr, 8, 77-82.

GROVES, R. M., SINGER, E. & CORNING, A. 2000. Leverage-saliency theory of survey participation: description and an illustration. Public Opin Q, 64, 299-308.

INTERNATIONAL PHARMACEUTICAL FEDERATION (FIP). 2019. Beating non-communicable diseases in the community - The contributions of pharmacists [Online]. The Hague, Netherlands: FIP. Available: [Accessed 4 October 2020].

KARIMI, N., MOORE, A. R., LUKIN, A., KANAZAKI, R., WILLIAMS, A. J. & CONNOR, S. 2020. Clinical communication in inflammatory bowel disease: a systematic literature review protocol. BMJ Open, 10, e039503.

KARPEN, S. C. 2018. The Social Psychology of Biased Self-Assessment. Am J Pharm Educ, 82, 6299.

KOLTUN, W. A. 2017. Better together: improved care of the IBD patient using the multi-disciplinary IBD center. Expert Rev Gastroenterol Hepatol, 11, 491-493.

KOVACS, R. J., LAGARDE, M. & CAIRNS, J. 2020. Overconfident health workers provide lower quality healthcare. Journal of Economic Psychology, 76, 102213.

LEE, C. K. & MELMED, G. Y. 2017. Multidisciplinary Team-Based Approaches to IBD Management: How Might "One-Stop Shopping" Work for Complex IBD Care? Am J Gastroenterol, 112, 825-827.

LOUIS, E., DOTAN, I., GHOSH, S., MLYNARSKY, L., REENAERS, C. & SCHREIBER, S. 2015. Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations. J Crohns Colitis, 9, 685-91.

MANOLAKIS, P. G. & SKELTON, J. B. 2010. Pharmacists' contributions to primary care in the United States collaborating to address unmet patient care needs: the emerging role for pharmacists to address the shortage of primary care providers. Am J Pharm Educ, 74, S7.

MASSUGER, W., MOORE, G. T. C., ANDREWS, J. M., KILKENNY, M. F., REYNEKE, M., KNOWLES, S., PURCELL, L., ALEX, G., BUCKTON, S., PAGE, A. T., STOCKS, N., CAMERON, D., MANGLAVITI, F. & PAVLI, P. 2019. Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia. Intern Med J, 49, 859-866.

MCGREGOR, S. 2004. Learning with Donald Rumsfeld - flexible learning: the relevance and resonance of multiprofessional learning in primary care. Br J Gen Pract, 54, 722-3.

MIKOCKA-WALUS, A., ANDREWS, J. M., RAMPTON, D., GOODHAND, J., VAN DER WOUDE, J. & BERNSTEIN, C. N. 2014. How can we improve models of care in inflammatory bowel disease? An international survey of IBD health professionals. J Crohns Colitis, 8, 1668-74.

MIKOCKA-WALUS, A., MASSUGER, W., KNOWLES, S. R., MOORE, G. T., BUCKTON, S., CONNELL, W., PAVLI, P., RAVEN, L. & ANDREWS, J. M. 2020. Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes. JGH Open, 4, 166-171.

PHARMACEUTICAL SOCIETY OF AUSTRALIA (PSA). 2019. Pharmacists in 2023: For patients, for our profession, for Australia’s health system [Online]. Available:

[Accessed 11 October 2020].

PHARMACY BOARD OF AUSTRALIA - APHRA. 2020. Pharmacy Board of Australia - Registrant data [Online]. Available: [Accessed 1 December 2020].

PHILLIPS, A. W., FRIEDMAN, B. T., UTRANKAR, A., TA, A. Q., REDDY, S. T. & DURNING, S. J. 2017. Surveys of Health Professions Trainees: Prevalence, Response Rates, and Predictive Factors to Guide Researchers. Acad Med, 92, 222-228.

PRASAD, S. S., DUNCANSON, K., KEELY, S., TALLEY, N. J., KAIRUZ, T., HOLTMANN, G. J., SHAH, A. & WALKER, M. M. 2020a. A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review. Pharmacy (Basel), 8.

PRASAD, S. S., KEELY, S., TALLEY, N. J., KAIRUZ, T. & WALKER, M. M. 2020b. Pharmacists' Confidence in Managing Patients with Inflammatory Bowel Disease. Pharmacy (Basel), 8.

PRASAD, S. S., POTTER, M., KEELY, S., TALLEY, N. J., WALKER, M. M. & KAIRUZ, T. 2020c. Roles of healthcare professionals in the management of chronic gastrointestinal diseases with a focus on primary care: A systematic review. JGH Open, 4, 221-229.

PRICEWATERHOUSECOOPERS (PWC) AUSTRALIA. 2013. Improving Inflammatory Bowel Disease care across Australia [Online]. Available: [Accessed 9 November 2020].

RICCI, C., LANZAROTTO, F. & LANZINI, A. 2008. The multidisciplinary team for management of inflammatory bowel diseases. Dig Liver Dis, 40 Suppl 2, S285-8.

STROHL, M., GONCZI, L., KURT, Z., BESSISSOW, T. & LAKATOS, P. L. 2018. Quality of care in inflammatory bowel diseases: What is the best way to better outcomes? World J Gastroenterol, 24, 2363-2372.

TAN, M., HOLLOWAY, R. H., LANGE, K. & ANDREWS, J. M. 2012. General practitioners' knowledge of and attitudes to inflammatory bowel disease. Intern Med J, 42, 801-7.

THE DEPARTMENT OF HEALTH. 2013. Primary Health Care in Australia [Online]. Department of Health. Available: [Accessed 21 October 2020].

VON ELM, E., ALTMAN, D. G., EGGER, M., POCOCK, S. J., GOTZSCHE, P. C., VANDENBROUCKE, J. P. & INITIATIVE, S. 2007. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet, 370, 1453-7.

ZEZOS, P. & PANISKO, D. 2018. Web-based learning in inflammatory bowel diseases: General truths and current specifics. World J Clin Cases, 6, 410-417.




How to Cite

Prasad, S. S., Keely, S., Talley, N. J., Duncanson, K., Kairuz, T., Jones, M. P., & Walker, M. M. (2022). Primary care pharmacists’ knowledge and perception of Inflammatory Bowel Disease: a cross-sectional study in Australia. ealth ducation in ractice: ournal of esearch for rofessional earning, 5(1).